NanJing Pharmaceutical Co Ltd - Asset Resilience Ratio
NanJing Pharmaceutical Co Ltd (600713) has an Asset Resilience Ratio of 0.85% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is NanJing Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1994–2012)
This chart shows how NanJing Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is NanJing Pharmaceutical Co Ltd's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down NanJing Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600713 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥290.51 Million | 0.85% |
| Total Liquid Assets | CN¥290.51 Million | 0.85% |
Asset Resilience Insights
- Limited Liquidity: NanJing Pharmaceutical Co Ltd maintains only 0.85% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NanJing Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare NanJing Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AstraZeneca PLC
LSE:AZN |
Drug Manufacturers - General | 0.06% |
|
Novartis AG ADR
NYSE:NVS |
Drug Manufacturers - General | 0.06% |
|
AstraZeneca PLC
NYSE:AZN |
Drug Manufacturers - General | 0.06% |
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 0.08% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Chongqing Lummy Pharmaceutical
SHE:300006 |
Drug Manufacturers - General | -0.19% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Firebrick Pharma Ltd
AU:FRE |
Drug Manufacturers - General | 0.29% |
Annual Asset Resilience Ratio for NanJing Pharmaceutical Co Ltd (1994–2012)
The table below shows the annual Asset Resilience Ratio data for NanJing Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2012-12-31 | 0.13% | CN¥12.43 Million ≈ $1.82 Million |
CN¥9.23 Billion ≈ $1.35 Billion |
+0.00pp |
| 2011-12-31 | 0.13% | CN¥11.99 Million ≈ $1.75 Million |
CN¥9.02 Billion ≈ $1.32 Billion |
-0.03pp |
| 2010-12-31 | 0.16% | CN¥13.42 Million ≈ $1.96 Million |
CN¥8.37 Billion ≈ $1.23 Billion |
+0.12pp |
| 2007-12-31 | 0.04% | CN¥2.16 Million ≈ $316.37K |
CN¥5.00 Billion ≈ $731.55 Million |
+0.03pp |
| 2006-12-31 | 0.01% | CN¥386.35K ≈ $56.54K |
CN¥3.69 Billion ≈ $539.56 Million |
-0.03pp |
| 2005-12-31 | 0.04% | CN¥1.49 Million ≈ $217.45K |
CN¥3.33 Billion ≈ $487.10 Million |
-0.04pp |
| 2004-12-31 | 0.09% | CN¥2.75 Million ≈ $402.70K |
CN¥3.13 Billion ≈ $458.62 Million |
-1.21pp |
| 2003-12-31 | 1.29% | CN¥34.02 Million ≈ $4.98 Million |
CN¥2.63 Billion ≈ $384.85 Million |
-0.57pp |
| 2002-12-31 | 1.87% | CN¥33.89 Million ≈ $4.96 Million |
CN¥1.82 Billion ≈ $265.78 Million |
+1.85pp |
| 2001-12-31 | 0.02% | CN¥186.89K ≈ $27.35K |
CN¥1.17 Billion ≈ $171.20 Million |
-3.86pp |
| 2000-12-31 | 3.87% | CN¥47.62 Million ≈ $6.97 Million |
CN¥1.23 Billion ≈ $179.88 Million |
+3.85pp |
| 1996-12-31 | 0.02% | CN¥107.25K ≈ $15.69K |
CN¥435.11 Million ≈ $63.67 Million |
-0.06pp |
| 1994-12-31 | 0.08% | CN¥218.33K ≈ $31.95K |
CN¥263.64 Million ≈ $38.58 Million |
-- |
About NanJing Pharmaceutical Co Ltd
Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nan… Read more